Oncology Today with Dr Neil Love cover image

Metastatic Bladder Cancer — Rapid Case Review Issue 3

Oncology Today with Dr Neil Love

00:00

How long to continue EV and pembrolizumab

Milowsky cites median cycles from EV302 and suggests up to 24 months for immunotherapy, tailoring EV to toxicity.

Play episode from 10:30
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app